Correlation Between Trevi Therapeutics and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Trevi Therapeutics and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Fennec Pharmaceuticals.
Diversification Opportunities for Trevi Therapeutics and Fennec Pharmaceuticals
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Trevi and Fennec is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Trevi Therapeutics and Fennec Pharmaceuticals
Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 1.56 times more return on investment than Fennec Pharmaceuticals. However, Trevi Therapeutics is 1.56 times more volatile than Fennec Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 185.00 in Trevi Therapeutics on September 14, 2024 and sell it today you would earn a total of 240.50 from holding Trevi Therapeutics or generate 130.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Trevi Therapeutics vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Trevi Therapeutics |
| Fennec Pharmaceuticals |
Trevi Therapeutics and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Trevi Therapeutics and Fennec Pharmaceuticals
The main advantage of trading using opposite Trevi Therapeutics and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |